How Roche Won The Bidding Battle For Spark
How Roche Won The Bidding Battle For Spark
$131.00
Go behind the scenes with Scrip, as expert analysts examine the machinations of Roche’s acquisition of Spark Therapeutics, Inc. Find out in this informative article how Roche secured the deal in the face of strong competition from three other rival companies.
Publisher: Scrip
- Description
Examine the behind-the-scenes action regarding Roche’s acquisition of Spark Therapeutics Inc. in this insightful article from Scrip. Analysts dissect a Securities and Exchange (SEC) commission filing by Spark to paint a picture of the skillful negotiating tactics employed by Spark CEO Jeff Marrazzo. See how his plan resulted in successfully driving up Spark’s per share price by more than 60% over its first offer, and how Roche ultimately secured the acquisition. Get the details on this $4.8b deal here.
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Breakthrough Designation Rescissions: Who Might US FDA Drop Next? 
Sign up to the